首页|牦牛胃溶菌酶抗小鼠腹泻的研究

牦牛胃溶菌酶抗小鼠腹泻的研究

扫码查看
本研究采用PichiaPinkTM毕赤酵母表达系统对牦牛胃溶菌酶进行异源表达,以探索提高重组牦牛胃溶菌酶表达量的方法以及重组牦牛胃溶菌酶对大肠杆菌O111所致小鼠腹泻的治疗作用.试验选取10只体重相近的无特定病原体昆明小鼠,用大肠杆菌O111建立小鼠腹泻模型;建模成功后取30只小鼠随机分为6组,每组5只,设对照组、腹泻模型组、牦牛胃溶菌酶组、重组牦牛胃溶菌酶组、抗生素治疗组、溶菌酶产品治疗组,除对照组和腹泻模型组外其余各组灌胃给药,记录小鼠采食量及体重;第4天采血后全部扑杀,取小鼠十二指肠组织制切片做形态学观察;取肠道内容物进行肠道菌群Alpha和Beta多样性分析.结果表明:重组牦牛胃溶菌酶在诱导96 h时表达量最高,分子质量约为15.6 ku,比活性为1 428.58 U/mg.攻毒后腹泻模型组、溶菌酶产品治疗组与对照组相比采食量显著降低(P<0.05);腹泻模型组与对照组相比,白细胞数、淋巴细胞数和中性粒细胞数均有极显著升高(P<0.01);十二指肠病理解剖观察发现,牦牛胃溶菌酶组肠道绒毛有所增长且厚度增加;重组牦牛胃溶菌酶组肠绒毛有所恢复.Alpha多样性分析发现,牦牛胃溶菌酶组的Simpson指数与对照组相比显著增加(P<0.05);腹泻模型组的变形菌门和弯曲杆菌门相对丰度显著增加(P<0.05);重组牦牛胃溶菌酶组和牦牛胃溶菌酶组的厚壁菌门和拟杆菌门相对丰度有所增加.本研究表明,牦牛胃溶菌酶对大肠杆菌引起的腹泻有较好的治疗效果.由于牦牛胃溶菌酶具备较强抗胃蛋白酶能力,其原酶及重组酶在饲料添加剂以及在食品加工和医疗卫生等领域具有一定的应用潜力.
Study on Resistance of Yak Stomach Lysozyme to Mice Diarrhea
This study aimed to express yak gastric lysozyme in PichiaPinkTM Pichia pastoris expression system to explore methods to improve the expression level of recombinant yak gastric lysozyme,and to investigate the therapeutic effect of recombinant yak gastric lysozyme on diarrhea caused by Escherichia coli O111 in mice.Ten mice with similar body weight were selected,and a mouse diarrhea model was established by Escherichia coli O111.After successful modeling,30 mice were randomly divided into six groups,with five mice in each group.A control group,a diarrhea model group,a yak gastric lysozyme group,a recombinant yak gastric lysozyme group,an antibiotic treatment group,and a lysozyme product treatment group were set up,excluding the con-trol group and the diarrhea model group,the rest of the groups were given oral administration,and the feed in-take and body weight of the mice were recorded.On the fourth day,all the mice were sacrificed,and the duo-denal tissue sections were prepared for morphological observation.The intestinal contents were analyzed for Al-pha and Beta diversity.The results showed that the highest expression level of recombinant yak gastric lyso-zyme was observed at 96 h after induction.The molecular weight was about 15.6 ku,and the specific activity was 1 428.58 U/mg.After challenge,the feed intake of the diarrhea model group,the lysozyme product treat-ment group,and the control group was significantly lower than that of the control group(P<0.05);compared with the control group,the white cell count,lymphocyte count,and neutrophil count of the diarrhea model group were significantly increased(P<0.01);the pathological observation of the duodenal tissue found that the intestinal villi of the yak gastric lysozyme group increased in length and thickness;the intestinal villi of the re-combinant yak gastric lysozyme group were restored.Alpha diversity analysis showed that the Simpson index of the yak gastric lysozyme group was significantly larger than that of the control group(P<0.05);the relative a-bundances of Proteobacteria and Citrobacter in the diarrhea model group were significantly increased(P<0.05);the relative abundances of Firmicutes and Bacteroidetes in the recombinant yak gastric lysozyme group and the yak gastric lysozyme group were increased.This study indicates that yak gastric lysozyme has a good therapeutic effect on diarrhea caused by Escherichia coli.Due to its strong resistance to gastric protease,the o-riginal enzyme and recombinant enzyme of yak gastric lysozyme have certain application potential in the fields of feed additives,food processing,and medical and health care.[Chinese Journal of Animal Nutrition,2024,36(3):1952-1963]

yak stomach lysozymePichiaPinkTM Pichia pastoris expression systemrecombinant yak stomach lysozymeintestinal floramice diarrhea

杨杜基、袁小迪、李飙、张雨寒、孙鸿炜、刘益丽、袁国荣、江明锋

展开 >

西南民族大学畜牧兽医学院,成都 610041

茂县科学技术和农业畜牧局,茂县 623200

牦牛胃溶菌酶 PichiaPinkTM毕赤酵母表达系统 重组牦牛溶菌酶 肠道菌群 小鼠腹泻

四川省科技计划四川省重点研发计划四川省科技计划

2023YFQ00762021YFN00012021YFYZ0001

2024

动物营养学报
中国畜牧兽医学会

动物营养学报

CSTPCD北大核心
影响因子:1.297
ISSN:1006-267X
年,卷(期):2024.36(3)
  • 27